Jiuliang Yan
- Topics
- Cancer Immunotherapy and Biomarkers (6 papers)Hepatocellular Carcinoma Treatment and Prognosis (4 papers)MicroRNA in disease regulation (3 papers)
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- SHILAP Revista de lepidopterologíaOncogeneBiochemical and Biophysical Research Communications
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Jiuliang Yan
18 papers receiving 349 citations
Peers
Comparison fields: 5 of 57
- Oncology 139
- Molecular Biology 133
- Immunology 113
- Cancer Research 95
- Pulmonary and Respiratory Medicine 73
Countries citing papers authored by Jiuliang Yan
This map shows the geographic impact of Jiuliang Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiuliang Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiuliang Yan more than expected).
Fields of papers citing papers by Jiuliang Yan
This network shows the impact of papers produced by Jiuliang Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiuliang Yan. The network helps show where Jiuliang Yan may publish in the future.
Co-authorship network of co-authors of Jiuliang Yan
This figure shows the co-authorship network connecting the top 25 collaborators of Jiuliang Yan. A scholar is included among the top collaborators of Jiuliang Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiuliang Yan. Jiuliang Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 9 | |
| 4 | 4 | |
| 5 | 13 | |
| 6 | 3 | |
| 7 | 21 | |
| 8 | 51 | |
| 9 | 7 | |
| 10 | 36 | |
| 11 | 2 | |
| 12 | GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma. | 16 |
| 13 | 48 | |
| 14 | 14 | |
| 15 | 15 | |
| 16 | 22 | |
| 17 | Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma. | 71 |
| 18 | 13 |
About Jiuliang Yan
Jiuliang Yan is a scholar working on Hepatology, Cancer Research and Oncology, having authored 18 papers that have together received 351 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (95 citations), Immunology (113 citations) and Oncology (139 citations). Jiuliang Yan has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Binghai Zhou, Qing‐Hai Ye, Yongfeng Xu, Yong‐Sheng Xiao, Mincheng Yu, Zheng Chen, Lei Guo, Jia Fan, Kewei Zhang and Bo Zhang. Their work appears in journals such as SHILAP Revista de lepidopterología, Oncogene and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.